Precision genome editing: a small revolution for glycobiology.

Precise and stable gene editing in mammalian cell lines has until recently been hampered by the lack of efficient targeting methods. While different gene silencing strategies have had tremendous impact on many biological fields, they have generally not been applied with wide success in the field of glycobiology, primarily due to their low efficiencies, with resultant failure to impose substantial phenotypic consequences upon the final glycosylation products. Here, we review novel nuclease-based precision genome editing techniques enabling efficient and stable gene editing, including gene disruption, insertion, repair, modification and deletion. The nuclease-based techniques comprised of homing endonucleases, zinc finger nucleases, transcription activator-like effector nucleases, as well as the RNA-guided clustered regularly interspaced short palindromic repeat/Cas nuclease system, all function by introducing single or double-stranded breaks at a defined genomic sequence. We here compare and contrast the different techniques and summarize their current applications, highlighting cases from the field of glycobiology as well as pointing to future opportunities. The emerging potential of precision gene editing for the field is exemplified by applications to xenotransplantation; to probing O-glycoproteomes, including differential O-GalNAc glycoproteomes, to decipher the function of individual polypeptide GalNAc-transferases, as well as for engineering Chinese Hamster Ovary host cells for production of improved therapeutic biologics.

[1]  Dana Carroll,et al.  Genome engineering with targetable nucleases. , 2014, Annual review of biochemistry.

[2]  N. Seidah,et al.  Low Density Lipoprotein Receptor Class A Repeats Are O-Glycosylated in Linker Regions* , 2014, The Journal of Biological Chemistry.

[3]  Huimin Zhao,et al.  Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. , 2014, Biotechnology and bioengineering.

[4]  Eric P. Bennett,et al.  High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs , 2014, Nucleic acids research.

[5]  B. Stoddard,et al.  Redesign of extensive protein–DNA interfaces of meganucleases using iterative cycles of in vitro compartmentalization , 2014, Proceedings of the National Academy of Sciences.

[6]  Jeffry D. Sander,et al.  CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.

[7]  Jin-Soo Kim,et al.  Surrogate reporter-based enrichment of cells containing RNA-guided Cas9 nuclease-induced mutations , 2014, Nature Communications.

[8]  J. Keith Joung,et al.  Broad Specificity Profiling of TALENs Results in Engineered Nucleases With Improved DNA Cleavage Specificity , 2014, Nature Methods.

[9]  T. Yamaji,et al.  Establishment of HeLa Cell Mutants Deficient in Sphingolipid-Related Genes Using TALENs , 2014, PloS one.

[10]  J. Keith Joung,et al.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs , 2014, Nature Biotechnology.

[11]  Thomas Gaj,et al.  Cell-Penetrating Peptide-Mediated Delivery of TALEN Proteins via Bioconjugation for Genome Engineering , 2014, PloS one.

[12]  Yuanxi Feng,et al.  A robust TALENs system for highly efficient mammalian genome editing , 2014, Scientific Reports.

[13]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[14]  Jin-Soo Kim,et al.  Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases , 2014, Genome research.

[15]  Yilong Li,et al.  Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.

[16]  E. Wolf,et al.  Protein O-mannosylation is crucial for E-cadherin–mediated cell adhesion , 2013, Proceedings of the National Academy of Sciences.

[17]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[18]  Tetsushi Sakuma,et al.  Repeating pattern of non-RVD variations in DNA-binding modules enhances TALEN activity , 2013, Scientific Reports.

[19]  David Baker,et al.  megaTALs: a rare-cleaving nuclease architecture for therapeutic genome engineering , 2013, Nucleic acids research.

[20]  S. Futaki,et al.  Creating a TALE protein with unbiased 5'-T binding. , 2013, Biochemical and biophysical research communications.

[21]  Feng Zhang,et al.  Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.

[22]  P. Thakore,et al.  Erratum: Reading Frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients (Molecular Therapy (2013) 21 (1718-1726) DOI: 10.1038/mt.2013.111) , 2013 .

[23]  E. Bennett,et al.  Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins , 2013, Proceedings of the National Academy of Sciences.

[24]  Prashant Mali,et al.  Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing , 2013, Nature Methods.

[25]  G. Church,et al.  Cas9 as a versatile tool for engineering biology , 2013, Nature Methods.

[26]  T. Cathomen,et al.  Histone deacetylase inhibition rescues gene knockout levels achieved with integrase-defective lentiviral vectors encoding zinc-finger nucleases. , 2013, Human gene therapy methods.

[27]  D. Segal,et al.  Genome engineering at the dawn of the golden age. , 2013, Annual review of genomics and human genetics.

[28]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[29]  C. Barbas,et al.  Directed evolution of the TALE N-terminal domain for recognition of all 5′ bases , 2013, Nucleic acids research.

[30]  S. Nelson,et al.  SGK196 Is a Glycosylation-Specific O-Mannose Kinase Required for Dystroglycan Function , 2013, Science.

[31]  D. Spector,et al.  Receptor-mediated delivery of engineered nucleases for genome modification , 2013, Nucleic acids research.

[32]  Nicholas E. Propson,et al.  Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis , 2013, Proceedings of the National Academy of Sciences.

[33]  David R. Liu,et al.  High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity , 2013, Nature Biotechnology.

[34]  Gang Bao,et al.  CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity , 2013, Nucleic acids research.

[35]  Natalie R. Sealover,et al.  Engineering Chinese hamster ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN)-mediated gene knockout of mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (Mgat1). , 2013, Journal of biotechnology.

[36]  Wei Yan,et al.  Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing , 2013, Scientific Reports.

[37]  G. Church,et al.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.

[38]  Eli J. Fine,et al.  DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.

[39]  Edward J. O'Brien,et al.  Genomic landscapes of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus draft genome , 2013, Nature Biotechnology.

[40]  J. Keith Joung,et al.  High frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells , 2013, Nature Biotechnology.

[41]  Charles A Gersbach,et al.  Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Christof von Kalle,et al.  TALEN-based gene correction for epidermolysis bullosa. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  S. Brunak,et al.  Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology , 2013, The EMBO journal.

[44]  C. Burlak,et al.  Biallelic knockout of the α-1,3 galactosyltransferase gene in porcine liver-derived cells using zinc finger nucleases. , 2013, The Journal of surgical research.

[45]  Rudolf Jaenisch,et al.  One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.

[46]  J. Carette,et al.  Deciphering the Glycosylome of Dystroglycanopathies Using Haploid Screens for Lassa Virus Entry , 2013, Science.

[47]  Daniel F. Voytas,et al.  Compact designer TALENs for efficient genome engineering , 2013, Nature Communications.

[48]  Shondra M. Pruett-Miller,et al.  Expanding the Repertoire of Target Sites for Zinc Finger Nuclease-mediated Genome Modification , 2013, Molecular therapy. Nucleic acids.

[49]  Fyodor D Urnov,et al.  In vivo cleavage of transgene donors promotes nuclease‐mediated targeted integration , 2013, Biotechnology and bioengineering.

[50]  Marcello Maresca,et al.  Obligate Ligation-Gated Recombination (ObLiGaRe): Custom-designed nuclease-mediated targeted integration through nonhomologous end joining , 2013, Genome research.

[51]  Wolfgang Wurst,et al.  Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides , 2013, Proceedings of the National Academy of Sciences.

[52]  Jin-Soo Kim,et al.  Magnetic Separation and Antibiotics Selection Enable Enrichment of Cells with ZFN/TALEN-Induced Mutations , 2013, PloS one.

[53]  James E. DiCarlo,et al.  RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.

[54]  Moon-Soo Kim,et al.  Quantitative analysis of TALE–DNA interactions suggests polarity effects , 2013, Nucleic acids research.

[55]  M. Tomita,et al.  Quantitative assay for TALEN activity at endogenous genomic loci , 2013, Biology Open.

[56]  E. Bennett,et al.  Enhanced Mass Spectrometric Mapping of the Human GalNAc-type O-Glycoproteome with SimpleCells* , 2013, Molecular & Cellular Proteomics.

[57]  Kevin Kim,et al.  A TALEN genome-editing system for generating human stem cell-based disease models. , 2013, Cell stem cell.

[58]  Le Cong,et al.  Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.

[59]  Seung Woo Cho,et al.  Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.

[60]  Gabriela Plesa,et al.  Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5. , 2013, Human gene therapy.

[61]  Jennifer Doudna,et al.  RNA-programmed genome editing in human cells , 2013, eLife.

[62]  S. Ramakrishna,et al.  Stability of Zinc Finger Nuclease Protein Is Enhanced by the Proteasome Inhibitor MG132 , 2013, PloS one.

[63]  H. Freeze Understanding Human Glycosylation Disorders: Biochemistry Leads the Charge* , 2013, The Journal of Biological Chemistry.

[64]  Tobias Schmidt,et al.  A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes , 2012, Nature Biotechnology.

[65]  Henrik Clausen,et al.  Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family. , 2012, Biochimica et biophysica acta.

[66]  J. Keith Joung,et al.  TALENs: a widely applicable technology for targeted genome editing , 2012, Nature Reviews Molecular Cell Biology.

[67]  Daniel F. Voytas,et al.  Efficient TALEN-mediated gene knockout in livestock , 2012, Proceedings of the National Academy of Sciences.

[68]  Claudio Mussolino,et al.  TALE nucleases: tailored genome engineering made easy. , 2012, Current opinion in biotechnology.

[69]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[70]  G. Hausner,et al.  Homing endonucleases: DNA scissors on a mission. , 2012, Genome.

[71]  Daniel F. Voytas,et al.  Simple Methods for Generating and Detecting Locus-Specific Mutations Induced with TALENs in the Zebrafish Genome , 2012, PLoS genetics.

[72]  Eunji Kim,et al.  Precision genome engineering with programmable DNA-nicking enzymes , 2012, Genome research.

[73]  Peiqing Zhang,et al.  Identification of functional elements of the GDP-fucose transporter SLC35C1 using a novel Chinese hamster ovary mutant. , 2012, Glycobiology.

[74]  L. Mosyak,et al.  Engineering novel Lec1 glycosylation mutants in CHO–DUKX cells: Molecular insights and effector modulation of N‐acetylglucosaminyltransferase I , 2012, Biotechnology and bioengineering.

[75]  George M. Church,et al.  Iterative capped assembly: rapid and scalable synthesis of repeat-module DNA such as TAL effectors from individual monomers , 2012, Nucleic acids research.

[76]  Kelley W. Moremen,et al.  Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.

[77]  Lawrence A Tabak,et al.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.

[78]  H. Wandall,et al.  Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells , 2012, Proceedings of the National Academy of Sciences.

[79]  B. Kleinstiver,et al.  Monomeric site-specific nucleases for genome editing , 2012, Proceedings of the National Academy of Sciences.

[80]  Yongling Xiao,et al.  Use of Zinc Finger Nuclease Technology to Knock Out Efflux Transporters in C2BBe1 Cells , 2012, Current protocols in toxicology.

[81]  C. Frye,et al.  Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells , 2012, Biotechnology and bioengineering.

[82]  Rafael J. Yáñez-Muñoz,et al.  Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleases , 2012, Nucleic acids research.

[83]  Claudio Mussolino,et al.  Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects , 2012, Nucleic acids research.

[84]  Method of the Year 2011 , 2011, Nature Methods.

[85]  Alfred Pingoud,et al.  A novel zinc-finger nuclease platform with a sequence-specific cleavage module , 2011, Nucleic acids research.

[86]  Jin-Soo Kim,et al.  Surrogate reporters for enrichment of cells with nuclease-induced mutations , 2011, Nature Methods.

[87]  H. Wandall,et al.  Mining the O-glycoproteome using zinc-finger nuclease–glycoengineered SimpleCell lines , 2011, Nature Methods.

[88]  K. Handa,et al.  Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process , 2011, Proceedings of the National Academy of Sciences.

[89]  A. Bogdanove,et al.  TAL Effectors: Customizable Proteins for DNA Targeting , 2011, Science.

[90]  S. Brunak,et al.  A Systematic Study of Site-specific GalNAc-type O-Glycosylation Modulating Proprotein Convertase Processing* , 2011, The Journal of Biological Chemistry.

[91]  Jeffrey C. Miller,et al.  An unbiased genome-wide analysis of zinc-finger nuclease specificity , 2011, Nature Biotechnology.

[92]  Shondra M Pruett-Miller,et al.  High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases , 2011, Nature Methods.

[93]  Li Wang,et al.  Erratum: Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting (Nucleic Acids Research (2011) 39 (e82) DOI: 10.1093/nar/gkr218) , 2011 .

[94]  A. Bradley,et al.  Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells , 2011, Nature.

[95]  Claudio Mussolino,et al.  A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity , 2011, Nucleic acids research.

[96]  Kelvin H. Lee,et al.  The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line , 2011, Nature Biotechnology.

[97]  David R. Liu,et al.  Revealing Off-Target Cleavage Specificities of Zinc Finger Nucleases by In Vitro Selection , 2011, Nature Methods.

[98]  Yolanda Santiago,et al.  Efficient generation of a biallelic knockout in pigs using zinc-finger nucleases , 2011, Proceedings of the National Academy of Sciences.

[99]  Susan Lindquist,et al.  Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations , 2011, Cell.

[100]  T. Cathomen,et al.  Adding fingers to an engineered zinc finger nuclease can reduce activity. , 2011, Biochemistry.

[101]  Stan J. J. Brouns,et al.  Evolution and classification of the CRISPR–Cas systems , 2011, Nature Reviews Microbiology.

[102]  K. Taniuchi,et al.  Overexpression of GalNAc-transferase GalNAc-T3 Promotes Pancreatic Cancer Cell Growth , 2011, Oncogene.

[103]  Erin L. Doyle,et al.  Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.

[104]  Yusuke Nakamura,et al.  Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin. , 2011, Neoplasia.

[105]  Elo Leung,et al.  A TALE nuclease architecture for efficient genome editing , 2011, Nature Biotechnology.

[106]  P. Duchateau,et al.  Meganucleases and Other Tools for Targeted Genome Engineering: Perspectives and Challenges for Gene Therapy , 2011, Current gene therapy.

[107]  B. Stoddard,et al.  Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. , 2011, Structure.

[108]  Feng Zhang,et al.  Selection-Free Zinc-Finger Nuclease Engineering by Context-Dependent Assembly (CoDA) , 2010, Nature Methods.

[109]  Erin L. Doyle,et al.  Targeting DNA Double-Strand Breaks with TAL Effector Nucleases , 2010, Genetics.

[110]  L. Liaw,et al.  Targeted Genome Modification in Mice Using Zinc-Finger Nucleases , 2010, Genetics.

[111]  R. Owens,et al.  Recent advances in the production of proteins in insect and mammalian cells for structural biology. , 2010, Journal of structural biology.

[112]  B. Stoddard,et al.  Single-strand nicks induce homologous recombination with less toxicity than double-strand breaks using an AAV vector template , 2010, Nucleic acids research.

[113]  E. Bennett,et al.  O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 , 2010, The Journal of Biological Chemistry.

[114]  Jeffrey C. Miller,et al.  Highly efficient deletion of FUT8 in CHO cell lines using zinc‐finger nucleases yields cells that produce completely nonfucosylated antibodies , 2010, Biotechnology and bioengineering.

[115]  Athena W Wong,et al.  Enhancement of DNA uptake in FUT8‐deleted CHO cells for transient production of afucosylated antibodies , 2010, Biotechnology and bioengineering.

[116]  Yolanda Santiago,et al.  Zinc-finger nuclease-driven targeted integration into mammalian genomes using donors with limited chromosomal homology , 2010, Nucleic acids research.

[117]  Florian Gnad,et al.  Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.

[118]  Thuy D. Vo,et al.  Transient cold shock enhances zinc-finger nuclease–mediated gene disruption , 2010, Nature Methods.

[119]  Yusuke Nakamura,et al.  Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis. , 2010, Cancer research.

[120]  Robert J Chalkley,et al.  Mass Spectrometric Analysis, Automated Identification and Complete Annotation of O-Linked Glycopeptides , 2010, European journal of mass spectrometry.

[121]  Mariana Henriques,et al.  Guidelines to cell engineering for monoclonal antibody production. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[122]  Yolanda Santiago,et al.  BAK and BAX deletion using zinc‐finger nucleases yields apoptosis‐resistant CHO cells , 2010, Biotechnology and bioengineering.

[123]  Jens Boch,et al.  Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors , 2009, Science.

[124]  Matthew J. Moscou,et al.  A Simple Cipher Governs DNA Recognition by TAL Effectors , 2009, Science.

[125]  Jonathan E. Foley,et al.  Targeted mutagenesis in zebrafish using customized zinc-finger nucleases , 2009, Nature Protocols.

[126]  P. Stanley,et al.  Glycomics Profiling of Chinese Hamster Ovary Cell Glycosylation Mutants Reveals N-Glycans of a Novel Size and Complexity* , 2009, The Journal of Biological Chemistry.

[127]  L. Tabak,et al.  Isoform-specific O-Glycosylation of Osteopontin and Bone Sialoprotein by Polypeptide N-Acetylgalactosaminyltransferase-1* , 2009, The Journal of Biological Chemistry.

[128]  R. Jaenisch,et al.  Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.

[129]  Z. Li,et al.  Optimal and consistent protein glycosylation in mammalian cell culture. , 2009, Glycobiology.

[130]  G. Wiederschain,et al.  Essentials of glycobiology , 2009, Biochemistry (Moscow).

[131]  K. Medzihradszky,et al.  Affinity Enrichment and Characterization of Mucin Core-1 Type Glycopeptides from Bovine Serum* , 2009, Molecular & Cellular Proteomics.

[132]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[133]  David J Segal,et al.  Restricted spacer tolerance of a zinc finger nuclease with a six amino acid linker. , 2009, Bioorganic & medicinal chemistry letters.

[134]  Prashant Mali,et al.  Gene targeting of a disease-related gene in human induced pluripotent stem and embryonic stem cells. , 2009, Cell stem cell.

[135]  Robert J Chalkley,et al.  Identification of protein O-GlcNAcylation sites using electron transfer dissociation mass spectrometry on native peptides , 2009, Proceedings of the National Academy of Sciences.

[136]  Shondra M. Pruett-Miller,et al.  Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels , 2009, PLoS genetics.

[137]  D. Gold,et al.  Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells , 2008, Vaccine.

[138]  Liping Zhang,et al.  Glycobiology on the fly: developmental and mechanistic insights from Drosophila. , 2008, Glycobiology.

[139]  Ronnie J Winfrey,et al.  Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. , 2008, Molecular cell.

[140]  J. Orange,et al.  Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.

[141]  Toni Cathomen,et al.  Unexpected failure rates for modular assembly of engineered zinc fingers , 2008, Nature Methods.

[142]  A. Klug,et al.  Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases , 2008, Proceedings of the National Academy of Sciences.

[143]  Adam James Waite,et al.  An improved zinc-finger nuclease architecture for highly specific genome editing , 2007, Nature Biotechnology.

[144]  S. M. Van Patten,et al.  Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. , 2007, Glycobiology.

[145]  J. Rossi,et al.  RNAi therapeutics: principles, prospects and challenges. , 2007, Advanced drug delivery reviews.

[146]  Fyodor D Urnov,et al.  Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases , 2007, Proceedings of the National Academy of Sciences.

[147]  W. Tanner,et al.  Protein glycosylation, conserved from yeast to man: a model organism helps elucidate congenital human diseases. , 2006, Angewandte Chemie.

[148]  H. Narimatsu Human glycogene cloning: focus on β3-glycosyltransferase and β4-glycosyltransferase families , 2006 .

[149]  T. Strom,et al.  Polypeptide GalNAc-transferase T3 and Familial Tumoral Calcinosis , 2006, Journal of Biological Chemistry.

[150]  Jonathan C Trinidad,et al.  O-Linked N-Acetylglucosamine Proteomics of Postsynaptic Density Preparations Using Lectin Weak Affinity Chromatography and Mass Spectrometry*S , 2006, Molecular & Cellular Proteomics.

[151]  T. Starzl,et al.  Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys , 2005, Nature Medicine.

[152]  J. Esko,et al.  The sweet and sour of cancer: glycans as novel therapeutic targets , 2005, Nature Reviews Cancer.

[153]  Jeffrey C. Miller,et al.  Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.

[154]  T. Okada,et al.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[155]  Scott A McLuckey,et al.  Complementary structural information from a tryptic N-linked glycopeptide via electron transfer ion/ion reactions and collision-induced dissociation. , 2005, Journal of proteome research.

[156]  Shigeru Iida,et al.  Establishment of FUT8 knockout Chinese hamster ovary cells: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody‐dependent cellular cytotoxicity , 2004, Biotechnology and bioengineering.

[157]  J. Shabanowitz,et al.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[158]  Thomas Tuschl,et al.  siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.

[159]  J. Marth,et al.  A genetic approach to Mammalian glycan function. , 2003, Annual review of biochemistry.

[160]  Dana Carroll,et al.  Enhancing Gene Targeting with Designed Zinc Finger Nucleases , 2003, Science.

[161]  J. Lowe,et al.  Role of glycosylation in development. , 2003, Annual review of biochemistry.

[162]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[163]  R. Cummings,et al.  A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[164]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[165]  U. Galili,et al.  The α-Gal epitope (Galα1-3Galβ1-4GlcNAc-R) in xenotransplantation. , 2001, Biochimie.

[166]  S Chandrasegaran,et al.  Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. , 2000, Nucleic acids research.

[167]  H. Clausen,et al.  Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. , 1999, Biochimica et biophysica acta.

[168]  E. Bennett,et al.  Cloning and Expression of a Proteoglycan UDP-Galactose:β-Xylose β1,4-Galactosyltransferase I , 1999, The Journal of Biological Chemistry.

[169]  Carolyn R. Bertozzi,et al.  Essentials of Glycobiology , 1999 .

[170]  Nigel Jenkins,et al.  Getting the glycosylation right: Implications for the biotechnology industry , 1996, Nature Biotechnology.

[171]  S Chandrasegaran,et al.  Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[172]  R. O'neill Enzymatic release of oligosaccharides from glycoproteins for chromatographic and electrophoretic analysis. , 1996, Journal of chromatography. A.

[173]  G. Hart,et al.  Ubiquitous and temporal glycosylation of nuclear and cytoplasmic proteins , 1995 .

[174]  P. Rouet,et al.  Expression of a site-specific endonuclease stimulates homologous recombination in mammalian cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[175]  R. Cummings,et al.  2,6-branched mannose and the regulation of poly-N-acetyllactosamine biosynthesis in N-linked oligosaccharides of Chinese hamster ovary cells. , 1993, The Journal of biological chemistry.

[176]  G. Hart,et al.  Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase. , 1992, The Journal of biological chemistry.

[177]  D. Kingsley,et al.  Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[178]  D. Kingsley,et al.  Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.

[179]  D. Kingsley,et al.  Receptor-mediated endocytosis of low density lipoprotein: somatic cell mutants define multiple genes required for expression of surface-receptor activity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[180]  P. Stanley,et al.  Chinese hamster ovary cells selected for resistance to the cytotoxicity of phytohemagglutinin are deficient in a UDP-N-acetylglucosamine--glycoprotein N-acetylglucosaminyltransferase activity. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[181]  S. Kornfeld,et al.  Deficient uridine diphosphate-N-acetylglucosamine:glycoprotein N-acetylglucosaminyltransferase activity in a clone of Chinese hamster ovary cells with altered surface glycoproteins. , 1975, The Journal of biological chemistry.

[182]  J. Wright EVIDENCE FOR PLEIOTROPIC CHANGES IN LINES OF CHINESE HAMSTER OVARY CELLS RESISTANT TO CONCANAVALIN A AND PHYTOHEMAGGLUTININ-P , 1973, The Journal of cell biology.

[183]  E. Bennett,et al.  Glycoengineering of human cell lines using zinc finger nuclease gene targeting: SimpleCells with homogeneous GalNAc O-glycosylation allow isolation of the O-glycoproteome by one-step lectin affinity chromatography. , 2013, Methods in molecular biology.

[184]  T. Cathomen,et al.  The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. , 2013, Human gene therapy.

[185]  Yoshio Kato,et al.  targeted gene knockout by direct delivery of zinc-finger nuclease proteins , 2012 .

[186]  Jeffrey C. Miller,et al.  A rapid and general assay for monitoring endogenous gene modification. , 2010, Methods in molecular biology.

[187]  P. Linsley,et al.  Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application , 2010, Nature Reviews Drug Discovery.

[188]  P. Huertas,et al.  DNA resection in eukaryotes: deciding how to fix the break , 2010, Nature Structural &Molecular Biology.

[189]  Eunji Kim,et al.  Targeted chromosomal deletions in human cells using zinc finger nucleases. , 2010, Genome research.

[190]  D. Segal,et al.  The generation of zinc finger proteins by modular assembly. , 2010, Methods in molecular biology.

[191]  J. Mackay,et al.  Engineered Zinc Finger Proteins , 2010, Methods in Molecular Biology.

[192]  Toni Cathomen,et al.  Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[193]  Jeffry D. Sander,et al.  Oligomerized pool engineering (OPEN): an 'open-source' protocol for making customized zinc-finger arrays , 2009, Nature Protocols.

[194]  Y. Maeda,et al.  CHO glycosylation mutants: GPI anchor. , 2006, Methods in enzymology.

[195]  H. Narimatsu Human glycogene cloning: focus on beta 3-glycosyltransferase and beta 4-glycosyltransferase families. , 2006, Current opinion in structural biology.

[196]  P. Stanley,et al.  Lectin-resistant CHO glycosylation mutants. , 2006, Methods in enzymology.

[197]  J. Esko,et al.  CHO glycosylation mutants: proteoglycans. , 2006, Methods in enzymology.

[198]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[199]  D. Sachs,et al.  Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue , 2005, Nature Medicine.

[200]  S. Iida,et al.  Establishment of FUT 8 Knockout Chinese Hamster Ovary Cells : An Ideal Host Cell Line for Producing Completely Defucosylated Antibodies With Enhanced Antibody-Dependent Cellular Cytotoxicity , 2004 .

[201]  P. Stanley,et al.  Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations that encode truncated N-acetylglucosaminyltransferase I. , 2003, Glycobiology.

[202]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.

[203]  F. Calon,et al.  Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.

[204]  S Chandrasegaran,et al.  A detailed study of the substrate specificity of a chimeric restriction enzyme. , 1999, Nucleic acids research.

[205]  Jeffry D Sander,et al.  FLAsH assembly of TALeNs for high-throughput genome editing , 2022 .